2026年4月30日 19:27 ET 发布 · 更新于 6 个月前 · 1 个来源
Seaport Therapeutics Said to Raise $255 Million in IPO
bloomberg
·
原始报道
INFERY
Seaport Therapeutics Inc., a clinical-stage biotechnology company focused on antidepressants and anxiety drugs, raised nearly $255 million in an upsized US initial public offering that priced at the top of its marketed range, according to people familiar with the matter.
原文